China stroke primary prevention trial: Visit-to-visit systolic blood pressure variability is an independent predictor of primary stroke in hypertensive patients

Journal of the American Heart Association

Volumn 6, Issue 3, 2017, Pages

  Men, Xi ^a   Sun, Wei ^a   Fan, Fangfang ^a   Zhao, Min ^b   Huang, Xiao ^c   Wang, Yu ^b   Liu, Lishun ^d   Liu, Ran ^a   Sun, Weiping ^a   Peng, Qing ^a   Qin, Xianhui ^b   Tang, Genfu ^e   Li, Jianping ^a   Zhang, Yan ^a   Cai, Yefeng ^f   Hou, Fan Fan ^b   Wang, Binyan ^b   Xu, Xiping ^b,c   Cheng, Xiaoshu ^c   Sun, Ningling ^g   Huang, Yining ^a   Huo, Yong ^a   more..

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c NANCHANG UNIVERSITY   (China)

^d ANHUI MEDICAL UNIVERSITY   (China)

^e ANHUI UNIVERSITY   (China)

^f GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^g PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Hypertension; Stroke; Systolic blood pressure variability

Indexed keywords

ENALAPRIL; FOLIC ACID; ANTIHYPERTENSIVE AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHINA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PATIENT CODING; PREDICTIVE VALUE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK ASSESSMENT; VISIT TO VISIT SYSTOLIC BLOOD PRESSURE VARIABILITY; AGED; AMBULATORY CARE; BLOOD PRESSURE; CLINICAL TRIAL; COMPLICATION; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYSTOLE; TIME FACTOR;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CHINA; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OFFICE VISITS; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; SYSTOLE; TIME FACTORS;

EID: 85015039897     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.004350     Document Type: Article

References (31)

1. Rafael L, Mohsen N, Kyle F, Stephen L, Kenji S, Victor A, Jerry A, Timothy A, Rakesh A, Ahn SY. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163-2196.
2. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2011;123:e18-e209.
3. Charles W, Cathie S, Martin D, Joanna W, Peter S. Stroke. Lancet. 2003;362:1211-1224.
4. Lawes CMM, Hoorn SV, Rodgers A; For the International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513-1518.
5. WHO document. A global brief on hypertension. 2015. Available at http://www.who.int/cardiovascular_disease/publication/global_brief_hypertension/.Accessed December 23, 2016.
6. Liu LS. 2010 Chinese guidelines for the management of hypertension. Chin J Hypertens. 2011;39:579-615.
7. Chobanian A; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.
8. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697-701.
9. Parati G, Stergiou GS, Asmar R, Bilo G, De LP, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26:1505-1530.
10. Leenen FH. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome. Can J Cardiol. 2004;20(suppl B):77B-82B.
11. Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F, Bulpitt C, Chalmers J, Fagard R, Gleason A. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336:1121-1123.
12. Williams B, Lindholm LH, Sever P. Systolic pressure is all that matters. Lancet. 2008;371:2219-2221.
13. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895-905.
14. Tom M. When measurements are misleading: modelling the effects of blood pressure misclassification in the English population. BMJ. 2004;328:933.
15. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, Gutnikov SA, Edwards P, Mant D, Sackley CM. Change in stroke incidence, mortality, casefatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004;363:1925-1933.
16. Yong H, Jianping L, Xianhui Q, Yining H, Xiaobin W, Gottesman RF, Genfu T, Binyan W, Dafang C, Mingli H. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in china: the CSPPT randomized clinical trial. JAMA. 2015;313:1325-1335.
17. Bruce A, Brian MC, Stephen D, Barbara D, Laura H, Marc J, Larry M, Albert R, Julia S, Elaine U. Recommendations for blood pressure measurement in human and experimental animals; part 1: blood pressure measurement in humans. Hypertension. 2006;48:e3.
18. Paul M, Cara J, Levitan EB, Elizabeth H, Daichi S, Webber LS, Suzanne O, Richard R, Marie KW. Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care. J Hypertens. 2011;29:2332-2338.
19. Diaz KM, Tanner RM, Louise F, Levitan EB, Kristi R, Daichi S, Paul M. Visit-tovisit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension. 2014;64:965-982.
20. Lau KK, Wong YK, Chan YH, Teo KC, Chan KH, Li LSW, Cheung RTF, Siu CW, Shu LH, Tse HF. Visit-to-visit blood pressure variability as a prognostic marker in patients with cardiovascular and cerebrovascular diseases-relationships and comparisons with vascular markers of atherosclerosis. Atherosclerosis. 2014;235:230-235.
21. Paolo P, Stevo J. The role of cardiac autonomic function in hypertension and cardiovascular disease. Curr Hypertens Rep. 2009;11:199-205.
22. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Poulter NR, Sever PS. Effects of b blockers and calcium-channel blockers on withinindividual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469-480.
23. Krakoff LR. Fluctuation: does blood pressure variability matter? Circulation. 2012;126:525-527.
24. Wenhong L, Ran L, Wei S, Qing P, Weiwei Z, En X, Yan C, Meiping D, Yansheng L, Zhen H. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke. 2012;43:2916-2922.
25. Briant LJB, Charkoudian N, Hart EC. Sympathetic regulation of blood pressure in normotension and hypertension: when sex matters. Exp Physiol. 2015;101:219-229.
26. Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O'Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation. 1983;68:50-58.
27. Okada H, Fukui M, Tanaka M, Matsumoto S, Mineoka Y, Nakanishi N, Asano M, Yamazaki M, Hasegawa G, Nakamura N. Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes. Diabetes Care. 2013;36:1908-1912.
28. Kei A, Masahiro K, Rudolph S, Lutgarde T, Miki H, Michihiro S, Azusa H, Taku O, Ryusuke I, Hirohito M. Home blood pressure variability as cardiovascular risk factor in the population of Ohasama. Hypertension. 2012;61:61-69.
29. Chenhui T, Yuxi S, Neng D, Dachun X, Wei C, Jiguang W, Athanase P, Van Sloten TT, Jacques B, Safar ME. Prognostic significance of visit-to-visit systolic blood pressure variability: a meta-analysis of 77, 299 patients. J Clin Hypertens. 2015;17:107-115 (109).
30. Levitan EB, Niko K, Suzanne O, Stevo J, Paul M. Blood pressure measurement device, number and timing of visits, and intra-individual visit-to-visit variability of blood pressure. J Clin Hypertens. 2012;14:744-750.
31. Tully PJ, Debette S, Dartigues J-F, Helmer C, Artero S, Tzourio C. Antihypertensive drug use, blood pressure variability, and incident stroke risk in older adults. Stroke. 2016;47:1194-1200.